Definition
- Essential:
- Supratentorial tumour with morphological and immunohistochemical features of ependymoma AND
- Gene fusion involving YAP1
- Desirable:
- DNA methylation profile aligned with supratentorial ependymoma. YAP1 fusion positive
- No immunoreactivity for p65 (RELA) or L1CAM
- PAS-positive eosinophilic granular bodies
Numbers
- Uncommon
- Only described in the paediatric setting thus far
- Accounting for approximately 7% of all supratentorial ependymomas
- Account for 6-7.4% of supratentorial ependymomas
- M:F ratio is 0.3:1
Localisation
- Within or adjacent to the lateral ventricle
Molecular pathology
- YAP1-MAMLD1 fusions → recruitment of nuclear factor I (NFI) and TEA domain (TEAD) family members
CNS WHO grading
- Variable: Need to look at degree of anaplasia
Pathology
Microscopic
- Composed of relatively uniform cells with small to mediumsized round or angulated nuclei.
- Ependymal rosettes are present in some tumours.
- Highly variable Ki67
- The fibrillary matrix contains PAS-positive eosinophilic granular bodies
- Common findings:
- Vascular endothelial proliferation
- Dystrophic calcification
- Necrosis.
Macroscopic
- Similar to other ependymoma
- Circumscribed and focally haemorrhagic, with a soft consistency.
Origin
- PAX6-positive radial glial neural stem cells
Clinical features
- Raised intracranial pressure
- Focal neurological deficits
- Seizures
Radiology
- Tumours are typically isointense to cortex on T2w sequences with well-defined edges and a combination of cystic and multinodular components,
- Heterogenous enhancement of the solid components and variable perilesional oedema
Prognosis
- Despite lesion size, their prognosis appears better compared to other supratentorial ependymomas